Core Insights - The demand for respiratory infectious disease testing is rising sharply as flu peaks arrive across various regions, with significant sales growth in flu test kits reported by JD Health [1] - JD Health has established a special guarantee mechanism in collaboration with brand merchants to ensure stable supply without price increases in response to the growing user demand [1] - Multi-detection test kits that can simultaneously test for influenza A, influenza B, COVID-19, and mycoplasma pneumonia have emerged as a new trend this year [1] Group 1 - JD Health has formed an IVD (in vitro diagnostics) brand alliance with multiple test kit brands and manufacturers to predict flu season demand and ensure stable product supply during peak periods [1] - The company has upgraded its fulfillment efficiency, enabling priority receipt and rapid shelving of flu test kits, with some regions able to achieve delivery in as fast as half an hour [1] Group 2 - JD Health offers a comprehensive solution for flu prevention and treatment through its unique "medical-testing-diagnosis-drug" closed-loop service capability, allowing users to consult with doctors online after receiving test results [2] - The company plans to continue monitoring respiratory disease trends and user demand changes, leveraging its supply chain and medical service resources to support early screening and family health management during the flu season [2]